Clinical Trial Update: Expressive Helping for Stem Cell Transplant Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for Expressive Helping in stem cell transplant patients with hematologic malignancies; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy
• Stem Cell Transplantation

Snippet

Sponsor: Northwestern University | Conditions: Stem Cell Transplantation, Hematologic Malignancy | Phase 3 | Status: COMPLETED